It is currently Fri Apr 17, 2015 8:37 pm
Carl Icahn raises the stakes for Big Pharma
The financier has set a high benchmark for bidders for the biotech firm. Fortune's John Simons explains why Big Pharma is likely to pay top dollar for a very risky asset.
Total posts 224743 • Total topics 23501 • Total members 14892